In this educational video Dr. Ashley Frazee explains the biology of chronic inflammation, focusing on the NF‑κB pathway and how its dysregulation leads to persistent low‑grade inflammation that underlies many diseases. She critiques current anti‑inflammatory strategies—NSAIDs, steroids, and biologics—highlighting their mechanisms, benefits, and drawbacks. The core of the presentation is the three‑amino‑acid peptide KPV, a fragment of the hormone α‑MSH. Frazee describes how KPV enters cells via the PEPT1 peptide transporter (which preferentially transports di‑ and tri‑peptides and is up‑regulated in inflamed gut and skin cells), where it interferes with NF‑κB activation, effectively pulling the “firefighter” away from the inflammation alarm button. She reviews pre‑clinical evidence: animal models of inflammatory bowel disease showing reduced cytokine expression, less colon shortening, preserved barrier function, and improved weight loss; nanoparticle‑encapsulated oral delivery that further enhances tissue targeting; additional cell and animal studies indicating reduced edema, improved wound healing, and direct antimicrobial activity against Candida and Staphylococcus aureus. Frazee stresses that no randomized human trials exist, and that most data are limited to cellular and animal work. She outlines the anecdotal side‑effect profile (mild GI upset with oral use, injection site irritation) and warns about the gray‑market availability of unregulated KPV products, urging caution. Finally, she discusses the potential for symptom rebound after stopping KPV, emphasizing that the underlying trigger of inflammation must be addressed for lasting benefit. The video concludes with a balanced view: KPV is a promising mechanistic tool that could inspire more precise anti‑inflammatory therapies, but it is not a proven replacement for established medicines.
Chapters
This is an anti-inflammatory signal. Currently, August 2026, it's a gray market peptide that works uniquely different from something like this or this. But the biological idea behind it could be incredibly powerful for the future of medicine. That is, as long as we understand exactly how it works, where the evidence ends, and not only what happens when we use it, but what happens when we stop using it. This is KPV. Millions of people suffer from chronic inflammation because their cellular inflammation alarm gets locked in the on position. In this video, we're going to uncover how a tiny 3-amino acid fragment derived from one of our own hormones could act like a master key to shut off that alarm at its root. But you also need to know what the internet gets dangerously wrong about using this currently unapproved peptide. So here's the thing. Inflammation is not always bad. It's our body's way of defending itself. Think of a bacteria entering your system. What naturally happens is that the cell senses it. It knows it's there, and it sets off a very specific cascade to get rid of the intruder. Picture for me, if you will, a firefighter just chilling in his break room if nothing is going on, but he's also hooked to his phone, which keeps him distracted enough from the shiny alarm button sitting next to him in the control room. But when a fire gets called in, it's like somebody comes and kicks the phone out of the firefighter's hand. He gets excited. He runs into the control room to smash that inflammation alarm button, and all the fire trucks get deployed. In this story, the firefighter is like our master switch of inflammation, NF-kappaB. It's a protein that can run into your DNA's control room and switch on inflammation. And the phone that keeps distracting the firefighter is iKappaB. When inflammation isn't needed, iKappaB is kind of always hanging out with NF-kappaB to keep it occupied and out of the control room. Naturally, in a working system, the fire gets put out and the firefighter finds his phone and goes back to chilling in the break room. But sometimes, in some people and in some circumstances, iKappaB, the phone, gets broken or lost. Or a nonstop barrage of invaders or thieves just keep coming in to steal every phone the firefighter has access to. And so the firefighter just keeps pushing the shiny button. And that, my friends, is basically how chronic inflammation works at the level of your DNA. And here are the 3 main ways that the alarm button can get stuck in the on position. 1, the missing phone. DNA glitches can block the cell from sending the firefighter a new phone. So that no one ever comes to drag the firefighter out of the control room and distract it. Number 2, the endless intruder signal. Well, constant irritants like high blood sugar, toxins, even leaky gut syndrome or inflammation in the gut lining, or chronic cortisol elevation from stress can keep setting off sensors that shoot down or steal every new phone the second that it gets delivered. Number 3, super gluing the switch down. Well, under heavy oxidative and cellular stress, The firefighter gets hyped up and hyperfocused on that on button. Normally, the cell calms him down so that he can step away, but under heavy stress, the cell loses its ability to calm him down. So he refuses to let go of the button, even if somebody walks in and hands him his phone. It's kind of like he got hyperfixated on the button and started doom scrolling on it instead. So instead of a short-lived inflammation response that eliminates a threat to the body, you get low-grade, nonstop inflammation that Gradually damages tissue, and it helps drive things like autoimmune diseases, metabolic dysfunction, and even chronic pain. So let me show you really quick how we typically deal with these situations. If the firefighter is pushing the button and keeps deploying fire trucks, one option is to block what those trucks do. That's essentially what NSAIDs like ibuprofen do. They reduce prostaglandins, some of the downstream messengers of inflammatory cytokines, which are responsible for pain, swelling, and fever. NSAIDs don't remove the firefighter from the control room, but they do limit some of the downstream effects. Steroids do shut down our firefighter friend NF-kappaB. They enter the control room and change the expression of a huge number of inflammatory genes. They grab the firefighter's hands and lock down the alarm button in the off position, while simultaneously sending droves of newly packaged phones to keep any other firefighters From trying to get into the control room. And while this tactic can be useful, steroids can backfire. They can impair blood flow and ultimately cause tissue breakdown with prolonged use, amongst other things. Then we have biologics, highly targeted drugs designed to intercept specific inflammatory signals like TNF-alpha or an interleukin like IL-6 or IL-8. Think of these like roadblocks placed in front of one particular fleet of fire trucks. If that fleet is driving the disease, biologics can make an enormous difference. But here's the real problem. People don't always get relief from those tactics, or they simply can't afford or get access to the ones that work the best. And so what do people do when there's a potential cheaper alternative with possibly no side effects? Enter the peptide KPV. Well, KPV proposes something different. Instead of blocking one inflammatory chemical after it's already been released, or broadly suppressing the entire fire department like steroids do, KPV appears to interfere with NF-kappaB. According to research, it's been shown to reduce the activation of NF-kappaB and the inflammatory signals that it produces. In other words, it may help pull the firefighter's hand away from the button. And I want to share with you how it does this because it's kind of fascinating, really. Back in the '80s and '90s, a team of scientists knew that the hormone alpha-MSH has the ability to produce profound anti-inflammatory effects. It's just that it also helps with skin pigmentation, appetite, metabolism, and a host of other things. So we can't just ramp up the hormone if we're just wanting the anti-inflammatory benefit from it. It really would mess with us. So the scientists got to work and isolated out the fragment of the hormone that interacts with NF-kappaB to shut it down. And something that's really fascinating about KPV is that unlike using the body's natural receptors for its parent hormone, alpha-MSH, KPV actually uses a special backdoor entrance. It gets transported into cells via a peptide transporter. Now you might be thinking, what? We have peptide transporters? Well, yeah, but not for peptides in this sense. They're for amino acid fragments, breakdown products of proteins that we eat. This is how we take protein into our cells and make use out of it. And there are peptide transporters that allow just 2 and 3 amino acid fragments into our cells. That's the only requirement to get in. You just have to be a 2 or 3 amino acid fragment. And KPV just so happens to be a 3-amino acid fragment. So it gets brought into cells this way via the PEPT1 transporter. But what's even more fascinating is that some cells, especially those in your gut lining or skin, when these become heavily inflamed, they actually upregulate PEPT1, building more doorways, trying to pull in more nutrients. For healing. But this allows a complete Trojan horse move for KPV. The inflamed cells open up extra doors looking for food and nutrients, and KPV slips right through them. It enters the cell and disarms NF-kappaB from the inside out. In other words, the more inflamed the tissue, the more doorways it creates for KPV to enter and put out the alarm. And this is why KPV has a significant amount of research in the irritable bowel disease space. Okay, so mechanistically this is really cool, but a cool mechanism doesn't automatically make something a great medicine. So let's go over what the research on KPV actually shows us. The greatest concentration of research we have right now on KPV is in intestinal inflammation, and this makes sense. Remember, the cells lining the gut already contain PEP-T1 transporters, and when those cells become inflamed, more of those receptors come to the surface. likely giving KPV more doorways into inflamed tissue. Using animals with inflammatory bowel disease, meaning Crohn's disease or ulcerative colitis, KPV has been associated with lower expression of inflammatory cytokines, less weight loss due to malabsorption, less shortening of the colon, which is a physical sign of severe inflammation, and better preservation of the intestinal barrier itself. And when scientists looked at the tissue under a microscope, they also found less inflammatory damage overall. And we also have some research that showed that the delivery of KPV could be even more specific. So instead of sending KPV throughout the body and hoping that it arrived in the right place, a study in 2017 in the journal Molecular Therapy showed that KPV could be packaged inside nanoparticles designed to accumulate in inflamed intestinal tissue, basically giving the Trojan horse a GPS signaling system. The targeted delivery appeared to work even better against inflammation. And in this study, they gave animals KPV orally. Now, this does not mean we have proven that swallowing or injecting a random vial of KPV will treat inflammatory bowel disease in a human. I can't claim that. But it does support the underlying biological idea. If you can deliver this tiny anti-inflammatory signal into inflamed intestinal cells, you may be able to reduce NF-kappaB signaling and protect the tissue from some of the damage. And the research doesn't just stop in the gut. We have more research in animals and cells showing that KPV can reduce the fluid and swelling that develop during inflammation, which may be why some people who have used KPV report improvement in inflammation in the skin. And we also have studies showing improvements in wound healing. But again, no randomized controlled human studies. But the research is promising. So now we have a 3-amino acid fragment that may calm the intracellular inflammation alarm. It may reduce the number of inflammatory first responders rushing into the tissue and potentially help preserve the barrier that those cells are trying to repair. But here's something I definitely have to mention. KPV may not only affect an inflammatory response to an intruder. It may actually affect the intruder itself. And this is just based on Petri dish science or cellular research, but we have a study showing KPV and related fragments of alpha-MSH having demonstrated a direct antimicrobial effect against organisms including Candida and Staph aureus, which is fascinating because it's doing it in a different way. So on one side, KPV appears to tell the firefighter, you can stop smashing that alarm right now. Go away, shut down the inflammation signal. But on the other side, it may also help deal with the thing that caused the firefighter to hit the alarm in the first place. And we don't know whether that can translate into actual antimicrobial effects in humans, but this could be huge because one of the biggest problems with broadly suppressing inflammation is that we have to keep in mind why the inflammation exists in the first place. If you completely shut down the fire department while an actual intruder is still inside the building, haven't solved the problem. You may have just silenced the response or put a Band-Aid on it. Yet knowing this doesn't seem to stop people from buying vials of KPV from the internet and trying it out. And this is just the problem with peptide use in general, right? Taking a fascinating unfinished story and skipping straight to the ending because we think it might work. Because if you search KPV online, you'll find injectable KPV, oral KPV, topical KPV, capsules marketed for gut health, creams marketed for skin, and Plenty of people say it completely changed their inflammation. And I'll be honest with you, I have seen people respond really well to KPV. I have seen rashes that wouldn't respond to prednisone respond to KPV. And I can't explain that. But I understand why people are fascinated by it and other peptides. There are enough compelling experiences with them solving issues for people that they couldn't get solved by their doctors or other ways. This is the problem with peptides. I mean, apart from the increasing amount of scams on the internet with research peptides. That's another problem for another video. But please just understand what I've said here. Most of the evidence supporting KPV still comes from cellular and animal research. We currently do not have any published human clinical trials establishing that KPV effectively treats inflammatory bowel disease, autoimmune disease, chronic pain or any of the other conditions that it typically gets used for. Still, people are doing it, which is why I make these videos, to try and educate people so that they understand what's really worth knowing, especially if they're going to be out there trying these things. And speaking of people using them, well, here are the side effects that people commonly report using this peptide. Again, this is all hearsay, but its side effect profile seems relatively low. When taken orally, especially by people with already inflamed GI systems, well, some report temporary nausea, mild cramping, or loose stools. And when injected, it comes with the same warnings that injectables all do: irritation, redness, or swelling at the site of injection. Put it in the comments if you've seen something else worth noting. And then there's one more part of this that I need to address. Theoretically, if someone were to use KPV for inflammation, What would happen when you stop? Well, let's go back to our firefighter. KPV may enter an inflamed cell and help pull his hand away from that alarm button. The inflammatory signals decrease, the tissue gets a chance to calm down and maybe even begin to repair itself. And I hinted at this earlier, but why was the firefighter hitting the button in the first place? Was it a persistent infection, ongoing gut barrier damage, uncontrolled blood sugars? An autoimmune response, maybe continued exposure to an irritant or an inflammatory signaling loop that's become capable of sustaining itself. Because KPV could interrupt the alarm, but it doesn't necessarily always remove the original intruder. So when KPV leaves the cell, the firefighter may look around, realize the threat is still standing there, throw his phone down, and hit the button all over again. So symptoms returning after stopping KPV may simply mean that the underlying condition Never left. Because it makes sense. Symptom suppression and resolution are not always the same thing. So people just need to understand that. If KPV eventually becomes a legitimate medical treatment, I don't think the most interesting question will be, does it lower inflammation? I think it does. The better question is, what else needs to be addressed so that the alarm stays off after the KPV is gone? KPV is not a proven replacement for ibuprofen, prednisone, biologics, or established treatments for inflammatory diseases. But I just love the biological possibility that it represents. Because current medicine is very good at blocking inflammatory signals after they've already been released. But maybe in the future we can get more precise. It's very exciting. The internet may be premature about KPV, but medicine may also be premature in ignoring what it represents. I'm Dr. Ashley Frazee. I just love the science of stuff like this, and I love sharing it with you. This video wasn't about encouraging you to buy peptides off the internet. Please be careful if you're doing that. It was just a tool for me to share what we already know. But if you are interested in learning more about peptides or just getting a really organized overview of the most common peptides worth knowing about, especially if you're a practitioner or someone who wants or needs to know more about peptides, I've built a course for that and I'll link it in the description. I hope you have the best day.
